Transformingcare.
PHYSICIANS
SPONSORS
PATIENTS
Let’s work together.
We’re taking on NASH with strong research partnerships and innovative approaches that leverage a proven platform. You can be part of it.
Featured news
International NASH Day – Bringing the disease into focus
Today, June 12, marks the third annual International NASH Day. The NASH Education Program started this campaign in 2018 to raise awareness and urgency around nonalcoholic fatty liver disease (NAFLD) and its more advanced form, nonalcoholic steatohepatitis (NASH). The Global Liver Institute continues to spearhead a consortium of patient advocacy organizations, as well as medical and professional groups, to shine ...
Our gut microbes influence our reactions to medications, new research shows.
A number of studies have found that certain strains of bacteria within a patient’s microbiome can impact their body’s response to medication – in both positive and negative ways. Read more to learn about these discoveries.
Evidence in favor of blood testing shows new technology surpassing anticipated milestones.
Despite past fraudulent claims about this technology from Theranos – the now-infamous and defunct healthcare company – blood testing capabilities are fast outpacing previous predictions in the medical field. Take a look at this FierceBiotech article to learn more.
Hydrogel pill for overweight or obese patients approved by FDA.
In 2019, the FDA approved the Gelesis100 oral hydrogel pill therapy for weight management. This capsule induces a feeling of fullness to help patients control their hunger without the drawback of added calories. Read more about this first-of-its-kind hydrogel pill therapy.